Product
Lanston
1 clinical trial
1 indication
Indication
Peptic UlcerClinical trial
A Multicenter, Parallel, Double-blind, Randomized, Active-controlled, Non-inferiority, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 Treatment in the Prevention of (NSAIDs)-Induced Peptic UlcersStatus: Not yet recruiting, Estimated PCD: 2027-08-01